We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADTX
13276
PUT
DELISTED
ADITXT INC
ADTX
0
ANIX icon
13277
CALL
Anixa Biosciences
ANIX
$110M
$39K ﹤0.01%
+10,100
New +$43K
BRN icon
13278
Barnwell Industries
BRN
$13.9M
$39K ﹤0.01%
11,749
-22,953
-66% -$65.4K
CRVS icon
13279
CALL
Corvus Pharmaceuticals
CRVS
$1.27B
$39K ﹤0.01%
14,700
-10,700
-42% -$29.5K
SLACW
13280
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$39K ﹤0.01%
+35,400
New +$36K
STON
13281
PUT
DELISTED
StoneMor Inc.
STON
$39K ﹤0.01%
14,800
-95,900
-87% -$218K
GCACW
13282
DELISTED
Growth Capital Acquisition Corp. Warrant
GCACW
$39K ﹤0.01%
62,861
-197
-0.3% -$98
BDSI
13283
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$39K ﹤0.01%
10,800
-4,000
-27% -$14.1K
NMAD
13284
Nomad Power Solutions
NMAD
$74.1M
$38K ﹤0.01%
1,239
-1,142
-48% -$32.8K
RMTI icon
13285
CALL
Rockwell Medical
RMTI
$29.6M
$38K ﹤0.01%
380
-290
-43% -$29.9K
TGB
13286
CALL
Trekor Metals
TGB
$3.08B
$38K ﹤0.01%
18,000
-23,500
-57% -$50.5K
TTNP
13287
CALL
DELISTED
Titan Pharmaceuticals
TTNP
$38K ﹤0.01%
735
-545
-43% -$27.3K
VTGN icon
13288
VistaGen Therapeutics
VTGN
$11.8M
$38K ﹤0.01%
399
-3,208
-89% -$238K
YARW
13289
PUT
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$38K ﹤0.01%
+12
New +$47.5K
RNTX
13290
Rein Therapeutics
RNTX
$67.4M
$38K ﹤0.01%
1,511
-831
-35% -$20.7K
ZSAN
13291
DELISTED
Zosano Pharma Corporation
ZSAN
$38K ﹤0.01%
1,148
-3,444
-75% -$111K
NEW
13292
PUT
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$38K ﹤0.01%
+2,120
New +$58.4K
CNET icon
13293
PUT
ZW Data Action Technologies
CNET
$4.88M
$37K ﹤0.01%
915
-810
-47% -$31.2K
IBIO icon
13294
iBio
IBIO
$69.5M
$37K ﹤0.01%
49
-55
-53% -$40.1K
MSN icon
13295
Emerson Radio
MSN
$7.99M
$37K ﹤0.01%
31,411
-9,648
-23% -$11.5K
RCG
13296
RENN Fund
RCG
$20.1M
$37K ﹤0.01%
+15,471
New +$40.3K
TOUR
13297
CALL
Tuniu
TOUR
$55.4M
$37K ﹤0.01%
1,560
-1,260
-45% -$34.4K
VAL.WS icon
13298
Valaris Ltd Warrants
VAL.WS
$835M
$37K ﹤0.01%
+12,862
New +$27.8K
AMPE
13299
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$37K ﹤0.01%
74
-82
-53% -$44K
NEW
13300
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$37K ﹤0.01%
2,089
-4,543
-69% -$125K

Similar funds

Citadel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
  • Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.